Cargando…
The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis
The advent of biological therapies has been a major therapeutic advance in rheumatology. Many patients now enjoy improved quality of life through better disease control. The number of therapies continues to grow both within drug class (including biosimilar drugs) and via new mechanisms. For the firs...
Autores principales: | Perry, Martin, Abdullah, Azhar, Frleta, Marina, MacDonald, Jonathan, McGucken, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011331/ https://www.ncbi.nlm.nih.gov/pubmed/32095163 http://dx.doi.org/10.1177/1759720X20904850 |
Ejemplares similares
-
Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study
por: O’Brien, Ciara M., et al.
Publicado: (2023) -
Lysozyme and its biological value in rheumatoid arthritis (RA)
por: Smirnow, J, et al.
Publicado: (2001) -
Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists
por: Choquette, Denis, et al.
Publicado: (2021) -
Bone Effects of Biologic Drugs in Rheumatoid Arthritis
por: Corrado, Addolorata, et al.
Publicado: (2013) -
Reconsidering the Role of Melatonin in Rheumatoid Arthritis
por: MacDonald, Iona J., et al.
Publicado: (2020)